Pharmaceutical pricing and access are like water in that they seek the fastest path. Countries like Australia and New Zealand have consistently dammed that path over many decades, primarily to divert the water, slow it down, and give themselves time to secure the lowest prices. Is the US on the verge of shutting off the water?
We can't moan about another country doing what we've been doing for decades
October 12, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
CSL expands US manufacturing with $1.5bn investment to boost plasma therapy production
March 10, 2026 - - Latest News -
Labor’s FoI backdown is a welcome victory for transparency and accountability
March 10, 2026 - - Latest News -
Mark Butler steps in to block eye injection funding change after patient warnings
March 10, 2026 - - Latest News -
Pharmac says new agreement has improved access to treatment for New Zealanders
March 10, 2026 - - Latest News -
Island Pharmaceuticals expands antiviral program through Burnet Institute collaboration
March 9, 2026 - -
New cancer research highlights potential of narmafotinib to koost KRAS Inhibitor therapies
March 9, 2026 - - Australian Biotech -
Lateral Pharma secures key U.S. patent for novel neuropathic pain therapy
March 9, 2026 - - Australian Biotech

